These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32027707)
81. Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter. Diao L; Ekins S; Polli JE Mol Pharm; 2010 Dec; 7(6):2120-31. PubMed ID: 20831193 [TBL] [Abstract][Full Text] [Related]
82. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2. Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108 [TBL] [Abstract][Full Text] [Related]
83. Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way. Jurkiewicz D; Michalec K; Skowronek K; Nałęcz KA Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):797-805. PubMed ID: 28257821 [TBL] [Abstract][Full Text] [Related]
84. Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice. Shekhawat PS; Srinivas SR; Matern D; Bennett MJ; Boriack R; George V; Xu H; Prasad PD; Roon P; Ganapathy V Mol Genet Metab; 2007 Dec; 92(4):315-24. PubMed ID: 17884651 [TBL] [Abstract][Full Text] [Related]
85. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. Ohnishi S; Okamura N; Sakamoto S; Hasegawa H; Norikura R; Kanaoka E; Takahashi K; Horie K; Sakamoto K; Baba T Drug Metab Pharmacokinet; 2008; 23(4):293-303. PubMed ID: 18762717 [TBL] [Abstract][Full Text] [Related]
86. Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter. Frigeni M; Iacobazzi F; Yin X; Longo N Biochim Biophys Acta; 2016 Jun; 1860(6):1334-42. PubMed ID: 26994919 [TBL] [Abstract][Full Text] [Related]
87. Deficiency of the carnitine transporter (OCTN2) with partial N-acetylglutamate synthase (NAGS) deficiency. Hwu WL; Chien YH; Tang NL; Law LK; Lin CY; Lee NC J Inherit Metab Dis; 2007 Oct; 30(5):816. PubMed ID: 17703373 [TBL] [Abstract][Full Text] [Related]
88. Carnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 Null (OCTN2(-/-)) Mice. Shekhawat PS; Yang HS; Bennett MJ; Carter AL; Matern D; Tamai I; Ganapathy V Pediatr Res; 2004 Sep; 56(3):323-8. PubMed ID: 15240869 [TBL] [Abstract][Full Text] [Related]
89. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Hirano T; Yasuda S; Osaka Y; Kobayashi M; Itagaki S; Iseki K Biochim Biophys Acta; 2006 Nov; 1758(11):1743-50. PubMed ID: 16928358 [TBL] [Abstract][Full Text] [Related]
90. [Cellular uptake of TPS-L-carnitine synthesised as transporter-based renal targeting prodrug]. Li L; Zhu D; Sun X Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):936-40. PubMed ID: 23387232 [TBL] [Abstract][Full Text] [Related]
91. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. Elimrani I; Lahjouji K; Seidman E; Roy MJ; Mitchell GA; Qureshi I Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G863-71. PubMed ID: 12684216 [TBL] [Abstract][Full Text] [Related]
92. Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation. Li D; Liu J; Du W; Liu H; Xiao W; Song X; Fan Z; Ke C; Yu Q; Qin W; Tang Y; Pu X Biomed Pharmacother; 2017 Sep; 93():444-450. PubMed ID: 28666211 [TBL] [Abstract][Full Text] [Related]
93. Clozapine-induced reduction of l-carnitine reabsorption via inhibition/down-regulation of renal carnitine/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice. Wang W; Bai M; Jiang T; Li C; Li P; Zhou H; Wang Z; Li L; Jiang H Toxicol Appl Pharmacol; 2019 Jan; 363():47-56. PubMed ID: 30465787 [TBL] [Abstract][Full Text] [Related]
94. Assessment of biological responses of EpiAirway 3-D cell constructs versus A549 cells for determining toxicity of ambient air pollution. Zavala J; O'Brien B; Lichtveld K; Sexton KG; Rusyn I; Jaspers I; Vizuete W Inhal Toxicol; 2016; 28(6):251-9. PubMed ID: 27100558 [TBL] [Abstract][Full Text] [Related]
95. Characterization of organic cation/carnitine transporter family in human sperm. Xuan W; Lamhonwah AM; Librach C; Jarvi K; Tein I Biochem Biophys Res Commun; 2003 Jun; 306(1):121-8. PubMed ID: 12788076 [TBL] [Abstract][Full Text] [Related]
96. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936 [TBL] [Abstract][Full Text] [Related]
97. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Tang NL; Ganapathy V; Wu X; Hui J; Seth P; Yuen PM; Wanders RJ; Fok TF; Hjelm NM Hum Mol Genet; 1999 Apr; 8(4):655-60. PubMed ID: 10072434 [TBL] [Abstract][Full Text] [Related]
98. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis. Jiang T; Zhang Y; Bai M; Li P; Wang W; Chen M; Ma Z; Zeng S; Zhou H; Jiang H Toxicol Lett; 2019 Nov; 316():183-193. PubMed ID: 31437515 [TBL] [Abstract][Full Text] [Related]
99. Cross-generational effects of maternal exposure to imazalil on anaerobic components and carnitine absorption associated with OCTN2 expression in mice. Wang X; Hu L; Wang C; He B; Fu Z; Jin C; Jin Y Chemosphere; 2022 Dec; 308(Pt 3):136542. PubMed ID: 36150497 [TBL] [Abstract][Full Text] [Related]
100. Distribution, molecular structure and functional analysis of carnitine transporter (SLC22A5) in canine lens epithelial cells. Ochiai H; Kanemaki N; Sato R; Onda K Exp Anim; 2014; 63(4):467-73. PubMed ID: 25048262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]